Kai is the External Innovation Lead for Johnson & Johnson’s World Without Disease Accelerator and Lung Cancer Initiative. In this role he is responsible for identifying and evaluating external opportunities, in partnership with the Johnson & Johnson Global External Innovation network, to accelerate the development of an innovative portfolio of projects, assets and solutions in support of disease prevention, interception and cure.
Prior to joining Johnson & Johnson Innovation, he was Vice President for Global Innovation at the Japanese pharmaceutical company Shionogi. In academia he had successful tenures at the University of Cambridge and University College London where his research focused on cell-cycle control of chromosomal replication and cell division. He identified new drug targets and cancer biomarkers commercially developed by start-up and biopharmaceutical companies.
